B Bilgin Global Mod Global Mod 31 Ocak 2024 #1 Piramal Pharma revenue up 14% at ₹1,959 crore in Q3 Piramal Pharma launched three new injectable products in the US and Europe during the quarter and is developing a pipeline of 25 new products targeting a market opportunity of over $2 billion
Piramal Pharma revenue up 14% at ₹1,959 crore in Q3 Piramal Pharma launched three new injectable products in the US and Europe during the quarter and is developing a pipeline of 25 new products targeting a market opportunity of over $2 billion
